Today in News History

On July 12, several notable moments in the history of News stand out. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1928, Elias James Corey, American chemist and academic, Nobel Prize laureate was born. In 1937, Mickey Edwards, American lawyer and politician was born. In 1947, Richard C. McCarty, American psychologist and academic was born. In 1948, Richard Simmons, American fitness trainer and actor (died 2024) was born. In 1959, Karl J. Friston, English psychiatrist and neuroscientist was born. In 1985, Ismael Londt, Surinamese-Dutch kickboxer was born. In 1991, Pablo Carreño Busta, Spanish tennis player was born. In 1996, Jordan Romero, American mountaineer was born. In 2014, Alfred de Grazia, American political scientist and author (born 1919) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

Willem Els and Richard Chelin: Fake weight-loss drugs flood the market, and Cat’s plea deal is rejected

BizNews

BizNews

·

July 1, 2026

·

center
Willem Els and Richard Chelin: Fake weight-loss drugs flood the market, and Cat’s plea deal is rejected
Narrative Intelligence Brief

This article was published by BizNews, a source frequently categorized with a center bias based in South Africa. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of BizNews, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 17%

Center 33%

Right 50%


BizNews

center

· Jul 12, 2026

Marika Sboros: Inside SA’s Ozempic copycat case exposing “Fat Drug” free-for-all

Marika Sboros: Inside SA’s Ozempic copycat case exposing “Fat Drug” free-for-all

National Post

lean right

· Jul 11, 2026

Colby Cosh: The drug that was approved on fake data

Behind the bureaucratic bluster, bad behaviour?

KLIF – 570AM – Dallas

right

· Jul 9, 2026

Ozempic Face, Blindness Claims, And Billions In Potential Damages: The GLP-1 Reckoning

Ozempic Lawsuits 2026 Side Effects 2B Claims Image by Radoslaw MaciejewskiShutterstock (1)A surge in demand for GLP-1 receptor agonist drugs su...

Voice of Nigeria

lean right

· Jun 29, 2026

FDA Reviews Sandoz Generic Obesity Drug Applications

The U.S. Food and Drug Administration (FDA) has accepted for review two generic versions of tirzepatide developed by Swiss pharmaceutical company Sandoz, a move that could pave the way for increased competition in the rapidly expanding obesity and diabetes treatment market. If approved, the medicines would become direct competitors to Eli Lilly’s blockbuster tirzepatide brands, [] The post FDA Reviews Sandoz Generic Obesity Drug Applications appeared first on Voice of Nigeria.

Drudge Retort

left

· Jun 26, 2026

One 79-year-old Patient Given Unapproved Powerful Obesity Drug

Speculation swirled around a report that a single patient -- a 79-year-old man -- was given access to a powerful new obesity drug that's still awaiting federal approval.

Palo Alto Online

center

· Jun 29, 2026

Gavin Newsom signs law limiting mental health diversion for people accused of crimes

This story was originally published by CalMatters. Sign up for their newsletters. Gov. Gavin Newsom has signed into law a change to criminal sentencing practices that gives judges more discretion to decide whether someone accused of a crime merits a mental health diversion. The bill overwhelmingly passed both chambers of the Legislature this year. Beginning []

Topics:

World · 4
Business · 1
Lifestyle · 1

Related coverage for "Willem Els and Richard Chelin: Fake weight-loss drugs flood the market, and Cat’s plea deal is rejected": BizNews — Marika Sboros: Inside SA’s Ozempic copycat case exposing “Fat Drug” free-for-all. National Post — Colby Cosh: The drug that was approved on fake data. KLIF – 570AM – Dallas — Ozempic Face, Blindness Claims, And Billions In Potential Damages: The GLP-1 Reckoning. Voice of Nigeria — FDA Reviews Sandoz Generic Obesity Drug Applications. Drudge Retort — One 79-year-old Patient Given Unapproved Powerful Obesity Drug. Palo Alto Online — Gavin Newsom signs law limiting mental health diversion for people accused of crimes